Last updated: March 30, 2020
Sponsor: National Taiwan University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Colon Cancer Screening
Treatment
N/AClinical Study ID
NCT04329585
201911072MIND
Ages 20-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
ASA I or II
plan to do colonoscopy
Exclusion
Exclusion Criteria:
existed CNS disease or injuries
known allergy to propofol, midazolam or alfentanil
Study Design
Total Participants: 60
Study Start date:
March 25, 2020
Estimated Completion Date:
March 31, 2022
Connect with a study center
National Taiwan University Cancer Center
Taipei, 106
TaiwanActive - Recruiting
National Taiwan University Hospital
Taipei, 100
TaiwanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.